{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:08Z","timestamp":1791118748020,"version":"4.1.0"},"reference-count":36,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"abstract":"<jats:p>Mineralocorticoid receptor (MR) antagonism reverses established inflammation, oxidative stress, and cardiac fibrosis in the mineralocorticoid\/salt-treated rat, whereas withdrawal of the mineralocorticoid deoxycorticosterone (DOC) alone does not. Glucocorticoid receptors (GRs) play a central role in regulating inflammatory responses but are also involved in cardiovascular homeostasis. Physiological glucocorticoids bind MR with high affinity, equivalent to that for aldosterone, but are normally prevented from activating MR by pre-receptor metabolism by 11\u03b2-hydroxysteroid dehydrogenase 2. We have previously shown a continuing fibrotic and hypertrophic effect after DOC withdrawal, putatively mediated by activation of glucocorticoid\/MR complexes; the present study investigates whether this effect is moderated by antiinflammatory effects mediated via GR. Uninephrectomized rats, drinking 0.9% saline solution, were treated as follows: control; DOC (20 mg\/wk) for 4 wk; DOC for 4 wk and no steroid wk 5\u20138; DOC for 4 wk plus the MR antagonist eplerenone (50 mg\/kg\u00b7d) wk 5\u20138; DOC for 4 wk plus the GR antagonist RU486 (2 mg\/d) wk 5\u20138; and DOC for 4 wk plus RU486 and eplerenone for wk 5\u20138. After steroid withdrawal, mineralocorticoid\/salt-induced cardiac hypertrophy is sustained, but not hypertension. Inflammation and fibrosis persist after DOC withdrawal, and GR blockade with RU486 has no effect on these responses. Rats receiving RU486 for wk 5\u20138 after DOC withdrawal showed marginal blood pressure elevation, whereas eplerenone alone or coadministered with RU486 reversed all DOC\/salt-induced circulatory and cardiac pathology. Thus, sustained responses after mineralocorticoid withdrawal appear to be independent of GR signaling, in that blockade of endogenous antiinflammatory effects via GR does not lead to an increase in the severity of responses in the mineralocorticoid\/salt-treated rat after steroid withdrawal.<\/jats:p>","DOI":"10.1210\/en.2007-0209","type":"journal-article","created":{"date-parts":[[2007,7,20]],"date-time":"2007-07-20T00:44:26Z","timestamp":1184892266000},"page":"4829-4835","source":"Crossref","is-referenced-by-count":18,"title":["Does Glucocorticoid Receptor Blockade Exacerbate Tissue Damage after Mineralocorticoid\/Salt Administration?"],"prefix":"10.1210","volume":"148","author":[{"given":"Amanda J.","family":"Rickard","sequence":"first","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Funder","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Morgan","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morag J.","family":"Young","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research, Clayton 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613573764100_R1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med [Erratum (2003) 348:2271]"},{"key":"2020071613573764100_R2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med [Erratum (2003) 348:2271]"},{"key":"2020071613573764100_R3","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"2020071613573764100_R4","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis.","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071613573764100_R5","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"2020071613573764100_R6","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physical Heart Circ Physiol"},{"key":"2020071613573764100_R7","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/endo.142.8.8339","article-title":"Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration.","volume":"142","author":"Fujisawa","year":"2001","journal-title":"Endocrinology"},{"key":"2020071613573764100_R8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/en.2002-220926","article-title":"Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11\u03b2-hydroxysteroid dehydrogenase inactivation.","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"2020071613573764100_R9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress.","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"2020071613573764100_R10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"2020071613573764100_R11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0039-128X(96)00020-7","article-title":"Mineralocorticoids, salt, hypertension: effects on the heart.","volume":"61","author":"Young","year":"1996","journal-title":"Steroids"},{"key":"2020071613573764100_R12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"2020071613573764100_R13","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats.","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"key":"2020071613573764100_R14","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1210\/en.2006-0826","article-title":"Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects.","volume":"147","author":"Funder","year":"2006","journal-title":"Endocrinology"},{"key":"2020071613573764100_R15","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/endo.137.12.8940344","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies.","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinology"},{"key":"2020071613573764100_R16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mce.2003.10.054","article-title":"Aldosterone, mineralocorticoid receptors and vascular inflammation.","volume":"217","author":"Funder","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613573764100_R17","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/en.2005-1527","article-title":"Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone\/salt rats.","volume":"147","author":"Lam","year":"2006","journal-title":"Endocrinology"},{"key":"2020071613573764100_R18","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1210\/en.2006-0658","article-title":"The role of the glucocorticoid receptor in mineralocorticoid\/salt mediated cardiac fibrosis.","volume":"147","author":"Rickard","year":"2006","journal-title":"Endocrinology"},{"key":"2020071613573764100_R19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jemt.1070320505","article-title":"Theory and practice of stereological techniques applied to the estimation of cell number and nuclear volume in the testis.","volume":"32","author":"Wreford","year":"1995","journal-title":"Microsc Res Tech"},{"key":"2020071613573764100_R20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00004872-199917030-00016","article-title":"Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism.","volume":"17","author":"Li","year":"1999","journal-title":"J Hypertens"},{"key":"2020071613573764100_R21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/jcem-67-4-824","article-title":"Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486.","volume":"67","author":"Clore","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613573764100_R22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1172\/JCI200111374","article-title":"A complex role for the progesterone receptor in the response to vascular injury.","volume":"108","author":"Karas","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071613573764100_R23","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/en.2004-0510","article-title":"Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells.","volume":"145","author":"Simoncini","year":"2004","journal-title":"Endocrinology"},{"key":"2020071613573764100_R24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/07853899309147861","article-title":"Dose-response relationships of RU 486.","volume":"25","author":"Heikinheimo","year":"1993","journal-title":"Ann Med"},{"key":"2020071613573764100_R25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0022-4731(87)90160-9","article-title":"Pharmacokinetics and metabolism of RU 486.","volume":"27","author":"Lahteenmaki","year":"1987","journal-title":"J Steroid Biochem"},{"key":"2020071613573764100_R26","first-page":"401","article-title":"Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.","volume":"241","author":"Kawai","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071613573764100_R27","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.","author":"Young","year":"1995","journal-title":"Am J Physiol 269(4 Pt 1)"},{"key":"2020071613573764100_R28","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/endo.137.10.8828470","article-title":"High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes.","volume":"137","author":"Sato","year":"1996","journal-title":"Endocrinology"},{"key":"2020071613573764100_R29","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"2020071613573764100_R30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/01.HYP.0000158845.49943.5e","article-title":"Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.","volume":"45","author":"Touyz","year":"2005","journal-title":"Hypertension"},{"key":"2020071613573764100_R31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.35.5.1099","article-title":"Role of 11\u03b2-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries.","volume":"35","author":"Alzamora","year":"2000","journal-title":"Hypertension"},{"key":"2020071613573764100_R32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries.","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"key":"2020071613573764100_R33","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1633591100","article-title":"Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor.","volume":"100","author":"Fjeld","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613573764100_R34","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1069300","article-title":"Regulation of corepressor function by nuclear NADH.","volume":"295","author":"Zhang","year":"2002","journal-title":"Science"},{"key":"2020071613573764100_R35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2005.07.005","article-title":"The Drosophila nuclear receptor e75 contains heme and is gas responsive.","volume":"122","author":"Reinking","year":"2005","journal-title":"Cell"},{"key":"2020071613573764100_R36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/148\/10\/4829\/10726202\/endo4829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/148\/10\/4829\/10726202\/endo4829.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T12:45:25Z","timestamp":1683981925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/148\/10\/4829\/2501565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2007-0209","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}